Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle

Purpose. The prognosis, treatment principles and prediction of clinical outcome of patients with chondrosarcoma currently rest on histologic grading which is somewhat ambiguous due to difficulty in pathologic interpretation of this neoplasm. Immunohistochemistry, flow cytometry and oncogene/tumor su...

Full description

Bibliographic Details
Main Authors: Sean P. Scully, Lester J. Layfield, John M. Harrelson
Format: Article
Language:English
Published: Hindawi Limited 1997-01-01
Series:Sarcoma
Online Access:http://dx.doi.org/10.1080/13577149778344
id doaj-a6ddb321df89424fb154d5803e50f3d3
record_format Article
spelling doaj-a6ddb321df89424fb154d5803e50f3d32020-11-25T00:06:43ZengHindawi LimitedSarcoma1357-714X1369-16431997-01-0112798710.1080/13577149778344Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell CycleSean P. Scully0Lester J. Layfield1John M. Harrelson2Section of Musculoskeletal Oncology, Duke University Medical Center, PO Box 3312, Durham 27710, NC, USASection of Musculoskeletal Oncology, Duke University Medical Center, PO Box 3312, Durham 27710, NC, USASection of Musculoskeletal Oncology, Duke University Medical Center, PO Box 3312, Durham 27710, NC, USAPurpose. The prognosis, treatment principles and prediction of clinical outcome of patients with chondrosarcoma currently rest on histologic grading which is somewhat ambiguous due to difficulty in pathologic interpretation of this neoplasm. Immunohistochemistry, flow cytometry and oncogene/tumor suppressor gene expression have been examined as alternative indices to predict the biologic behavior of these tumors. Because of partial successes obtained with flow cytometry and because of the improvement in predicting recurrence offered by examining the S-phase fraction, we undertook the current study to determine if expression of specific regulators of the cell cycle would act as prognostic indicators for these patients.http://dx.doi.org/10.1080/13577149778344
collection DOAJ
language English
format Article
sources DOAJ
author Sean P. Scully
Lester J. Layfield
John M. Harrelson
spellingShingle Sean P. Scully
Lester J. Layfield
John M. Harrelson
Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle
Sarcoma
author_facet Sean P. Scully
Lester J. Layfield
John M. Harrelson
author_sort Sean P. Scully
title Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle
title_short Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle
title_full Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle
title_fullStr Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle
title_full_unstemmed Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle
title_sort prognostic markers in chondrosarcoma: evaluation of cell proliferation and of regulators of the cell cycle
publisher Hindawi Limited
series Sarcoma
issn 1357-714X
1369-1643
publishDate 1997-01-01
description Purpose. The prognosis, treatment principles and prediction of clinical outcome of patients with chondrosarcoma currently rest on histologic grading which is somewhat ambiguous due to difficulty in pathologic interpretation of this neoplasm. Immunohistochemistry, flow cytometry and oncogene/tumor suppressor gene expression have been examined as alternative indices to predict the biologic behavior of these tumors. Because of partial successes obtained with flow cytometry and because of the improvement in predicting recurrence offered by examining the S-phase fraction, we undertook the current study to determine if expression of specific regulators of the cell cycle would act as prognostic indicators for these patients.
url http://dx.doi.org/10.1080/13577149778344
work_keys_str_mv AT seanpscully prognosticmarkersinchondrosarcomaevaluationofcellproliferationandofregulatorsofthecellcycle
AT lesterjlayfield prognosticmarkersinchondrosarcomaevaluationofcellproliferationandofregulatorsofthecellcycle
AT johnmharrelson prognosticmarkersinchondrosarcomaevaluationofcellproliferationandofregulatorsofthecellcycle
_version_ 1725420747558486016